146 related articles for article (PubMed ID: 9598480)
21. [Bladder cancer in spinal cord injury patient. A case report].
Kuwahara T; Kudo J; Tanaka J
Nihon Hinyokika Gakkai Zasshi; 1995 Nov; 86(11):1681-4. PubMed ID: 8551712
[TBL] [Abstract][Full Text] [Related]
22. Bladder cancer in the spinal cord-injured patient with long-term catheterization: a casual relationship?
Esrig D; McEvoy K; Bennett CJ
Semin Urol; 1992 May; 10(2):102-8. PubMed ID: 1636067
[No Abstract] [Full Text] [Related]
23. [The risk of cancer in neuropathic bladders].
Eichhorn F; Thon W; Altwein JE
Urol Int; 1984; 39(2):105-9. PubMed ID: 6719634
[TBL] [Abstract][Full Text] [Related]
24. The method of bladder drainage in spinal cord injury patients may influence the histological changes in the mucosa of neuropathic bladder - a hypothesis.
Vaidyanathan S; Mansour P; Soni BM; Singh G; Sett P
BMC Urol; 2002 Apr; 2():5. PubMed ID: 11980583
[TBL] [Abstract][Full Text] [Related]
25. Bladder cancer following administration of cyclophosphamide.
Durkee C; Benson R
Urology; 1980 Aug; 16(2):145-8. PubMed ID: 6250267
[TBL] [Abstract][Full Text] [Related]
26. Developing a strategy to reduce the high morbidity of patients with long-term urinary catheters: the BioMed catheter research clinic.
Khan AA; Mathur S; Feneley R; Timoney AG
BJU Int; 2007 Dec; 100(6):1298-301. PubMed ID: 17979927
[TBL] [Abstract][Full Text] [Related]
27. Bladder management after spinal cord injury in the United States 1972 to 2005.
Cameron AP; Wallner LP; Tate DG; Sarma AV; Rodriguez GM; Clemens JQ
J Urol; 2010 Jul; 184(1):213-7. PubMed ID: 20478597
[TBL] [Abstract][Full Text] [Related]
28. Cancer of the bladder in spinal cord injury patients.
Broecker BH; Klein FA; Hackler RH
J Urol; 1981 Feb; 125(2):196-7. PubMed ID: 7206053
[TBL] [Abstract][Full Text] [Related]
29. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
Schumm K; Lam TB
Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
[TBL] [Abstract][Full Text] [Related]
30. Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patient.
Tuttle TM; Williams GM; Marshall FF
J Urol; 1988 Nov; 140(5):1009-11. PubMed ID: 3050150
[TBL] [Abstract][Full Text] [Related]
31. Urethral versus suprapubic catheter: choosing the best bladder management for male spinal cord injury patients with indwelling catheters.
Katsumi HK; Kalisvaart JF; Ronningen LD; Hovey RM
Spinal Cord; 2010 Apr; 48(4):325-9. PubMed ID: 19823191
[TBL] [Abstract][Full Text] [Related]
32. Bladder stones in catheterized spinal cord-injured patients in Nigeria.
Kawu AA; Olawepo A; Salami O; Kuranga SA; Shamsi H; Jeje EA
Niger J Clin Pract; 2012; 15(2):156-8. PubMed ID: 22718163
[TBL] [Abstract][Full Text] [Related]
33. Chronic Indwelling Urinary Catheter Increase the Risk of Bladder Cancer, Even in Patients Without Spinal Cord Injury.
Ho CH; Sung KC; Lim SW; Liao CH; Liang FW; Wang JJ; Wu CC
Medicine (Baltimore); 2015 Oct; 94(43):e1736. PubMed ID: 26512566
[TBL] [Abstract][Full Text] [Related]
34. Community-care waiting list for persons with spinal cord injury.
Vaidyanathan S; Soni BM; Mansour P; Glass CA; Singh G; Bingley J; Watt JW; Sett P
Spinal Cord; 2001 Nov; 39(11):584-8. PubMed ID: 11641808
[TBL] [Abstract][Full Text] [Related]
35. Bladder histological changes associated with chronic indwelling urinary catheter.
Delnay KM; Stonehill WH; Goldman H; Jukkola AF; Dmochowski RR
J Urol; 1999 Apr; 161(4):1106-8; discussion 1108-9. PubMed ID: 10081848
[TBL] [Abstract][Full Text] [Related]
36. Iatrogenic bladder rupture in individuals with disability related to spinal cord injury and chronic indwelling urethral catheters.
Teplitsky SL; Leong JY; Shenot PJ
Spinal Cord Ser Cases; 2020 Jun; 6(1):47. PubMed ID: 32513945
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre.
Böthig R; Kurze I; Fiebag K; Kaufmann A; Schöps W; Kadhum T; Zellner M; Golka K
Int Urol Nephrol; 2017 Jun; 49(6):983-994. PubMed ID: 28332134
[TBL] [Abstract][Full Text] [Related]
38. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Lebrun C; Debouverie M; Vermersch P; Clavelou P; Rumbach L; de Seze J; Wiertlevski S; Defer G; Gout O; Berthier F; Danzon A
Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
[TBL] [Abstract][Full Text] [Related]
39. Isolated condyloma acuminatum of the bladder in a patient with multiple sclerosis: etiological and pathological considerations.
van Poppel H; Stessens R; de Vos R; van Damme B
J Urol; 1986 Nov; 136(5):1071-3. PubMed ID: 3773073
[TBL] [Abstract][Full Text] [Related]
40. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
